#HVO hVIVO PLC – Presentation at Jefferies Healthcare Conference November 3, 2025 – Posted in: hVIVO (HVO) – Tags: , , , , , , ,

hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that Yamin ‘Mo’ Khan, Chief Executive Officer, will be presenting in-person at the Jefferies Global Healthcare Conference in London on 20 November 2025 at 12.30pm GMT. Alongside the presentation, the Company will also be available for one-to-one meetings.

The Jefferies Global Healthcare Conference is the largest healthcare-dedicated conference in Europe and is taking place between the 17-20 November 2025 in London. The conference hosts over 700 healthcare companies, 3,600 attendees, and 10,000 investor and business-to-business meetings. The event brings together C-suite executives from leading public and private companies from the pharmaceuticals, biotechnology, medical technology, and healthcare services sectors from the Americas, Europe, Middle East, Africa, Asia, and Australia.

No new material information will be disclosed during the day and the PDF of the presentation will be made available on the Company’s website shortly after the event.

 

For further information please contact:

 

hVIVO plc

+44 (0)20 7756 1300

Yamin ‘Mo’ Khan, Chief Executive Officer

Stephen Pinkerton, Chief Financial Officer

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

+44 (0)20 7220 0500

Geoff Nash, Callum Davidson,

Trisyia Jamaludin, Harriet Ward

Nigel Birks – Life Science Specialist Sales

Louise Talbot – Sales

Peel Hunt LLP (Joint Broker)

+44 (0)20 7418 8900

James Steel, Dr Christopher Golden

Davy (Joint Broker)

+353 (0) 1 679 6363

Anthony Farrell, Niall Gilchrist

Walbrook PR (Financial PR & IR)

Paul McManus / Alice Woodings /

Lianne Applegarth

 

+44 (0) 20 7933 8780 or hvivo@walbrookpr.com

+44 (0)7980 541 893 / +44 (0)7407 804 654/

+44 (0)7584 391 303